News

Kepler Capital Sticks to Their Buy Rating for BB Biotech (0JYO)
Kepler Capital analyst Nicolas Pauillac maintained a Buy rating on BB Biotech (0JYO – Research Report) on April 25 and set a price target of ...
Kepler Capital Sticks to Their Buy Rating for Affluent Medical SA (0JZ)
In a report released on April 25, Nicolas Pauillac from Kepler Capital maintained a Buy rating on Affluent Medical SA (0JZ – Research Report), ...